| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68546-142-56 | 68546-142 | HUMAN PRESCRIPTION DRUG | Azilect | Rasagiline mesylate | TABLET | ORAL | 20060710 | N/A | NDA | NDA021641 | Teva Neuroscience, Inc. | RASAGILINE MESYLATE | .5 mg/1 | 30 TABLET in 1 BOTTLE (68546-142-56) |
| 0093-3061-56 | 0093-3061 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline | TABLET | ORAL | 20170103 | N/A | NDA AUTHORIZED GENERIC | NDA021641 | Teva Pharmaceuticals USA, Inc. | RASAGILINE MESYLATE | 1 mg/1 | 30 TABLET in 1 BOTTLE (0093-3061-56) |
| 0093-3060-56 | 0093-3060 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline | TABLET | ORAL | 20170103 | N/A | NDA AUTHORIZED GENERIC | NDA021641 | Teva Pharmaceuticals USA, Inc. | RASAGILINE MESYLATE | .5 mg/1 | 30 TABLET in 1 BOTTLE (0093-3060-56) |
| 68546-229-56 | 68546-229 | HUMAN PRESCRIPTION DRUG | Azilect | Rasagiline mesylate | TABLET | ORAL | 20060710 | N/A | NDA | NDA021641 | Teva Neuroscience, Inc. | RASAGILINE MESYLATE | 1 mg/1 | 30 TABLET in 1 BOTTLE (68546-229-56) |